|
US3169967A
(en)
|
1957-11-14 |
1965-02-16 |
Ciba Geigy Corp |
Methyl o-lower alkanoyl-reserpates
|
|
US3037980A
(en)
|
1955-08-18 |
1962-06-05 |
Burroughs Wellcome Co |
Pyrrolopyrimidine vasodilators and method of making them
|
|
US3506643A
(en)
|
1966-12-09 |
1970-04-14 |
Max Thiel |
N**6-aralkyl-adenosine derivatives
|
|
DE2139107A1
(de)
|
1971-08-04 |
1973-02-15 |
Merck Patent Gmbh |
Heterocyclisch substituierte adenosinverbindungen
|
|
US3962443A
(en)
|
1972-08-14 |
1976-06-08 |
Dainippon Pharmaceutical Co., Ltd. |
Antibacterial pharmaceutical compositions and processes for preparation thereof
|
|
DE2248232A1
(de)
|
1972-10-02 |
1974-04-11 |
Basf Ag |
4-thiopyrimido eckige klammer auf 4,5-d eckige klammer zu pyrimidine
|
|
AR204003A1
(es)
|
1973-04-03 |
1975-11-12 |
Dainippon Pharmaceutical Co |
Procedimiento para preparar compuestos derivados del acido 2-(1-piperazinil)-5-oxopirido-(2,3-d)pirimidino-6-carboxilico y sus sales farmaceuticamente aceptables
|
|
US3862189A
(en)
|
1973-08-14 |
1975-01-21 |
Warner Lambert Co |
Aralkyl-substituted purines and pyrimidines as antianginal bronchodilator agents
|
|
US3936454A
(en)
|
1973-08-14 |
1976-02-03 |
Warner-Lambert Company |
5-Amino-4-chloro-6-(substituted amino)-pyrimidines
|
|
DK3375A
(sr)
|
1974-01-25 |
1975-09-15 |
Ciba Geigy Ag |
|
|
JPS587626B2
(ja)
|
1974-02-13 |
1983-02-10 |
大日本製薬株式会社 |
ナフチリジン オヨビ キノリンユウドウタイノセイホウ
|
|
JPS5359663A
(en)
|
1976-11-09 |
1978-05-29 |
Sumitomo Chem Co Ltd |
2-halogeno methyl indole derivatives and process for praparation of the same
|
|
JPS52106897A
(en)
|
1977-01-10 |
1977-09-07 |
Dainippon Pharmaceut Co Ltd |
Synthesis of piperazine derivatives
|
|
JPS5392767A
(en)
|
1977-01-27 |
1978-08-15 |
Sumitomo Chem Co Ltd |
Preparation of 2-phthalimidomethylindole derivatives
|
|
JPS5625234A
(en)
|
1979-08-02 |
1981-03-11 |
Hitachi Denshi Ltd |
Dropout display system
|
|
JPS56123981A
(en)
|
1981-02-23 |
1981-09-29 |
Dainippon Pharmaceut Co Ltd |
Preparation of 1,4-disubstituted piperazine
|
|
JPS5883698A
(ja)
|
1981-11-13 |
1983-05-19 |
Takeda Chem Ind Ltd |
キノン化合物およびその製造法
|
|
JPS58162949A
(ja)
|
1982-03-20 |
1983-09-27 |
Konishiroku Photo Ind Co Ltd |
ハロゲン化銀カラ−写真感光材料
|
|
JPS6067709U
(ja)
|
1983-10-14 |
1985-05-14 |
三洋電機株式会社 |
ヘア−ドライヤ−
|
|
JPS60140373U
(ja)
|
1984-02-28 |
1985-09-17 |
東洋ハ−ネス株式会社 |
ワイヤハ−ネスのア−ス構造
|
|
JPS6190153A
(ja)
|
1984-10-09 |
1986-05-08 |
Fuji Photo Film Co Ltd |
ハロゲン化銀写真感光材料の処理方法
|
|
JPS6263591U
(sr)
|
1985-06-29 |
1987-04-20 |
|
|
|
JPS62103640A
(ja)
|
1985-07-18 |
1987-05-14 |
Fuji Photo Film Co Ltd |
ハロゲン化銀カラ−写真感光材料
|
|
JPS635783Y2
(sr)
|
1985-10-17 |
1988-02-17 |
|
|
|
JPH07119970B2
(ja)
|
1986-04-18 |
1995-12-20 |
富士写真フイルム株式会社 |
画像形成方法
|
|
JPS6310746A
(ja)
|
1986-07-01 |
1988-01-18 |
Tanabe Seiyaku Co Ltd |
ナフタレン誘導体
|
|
CA1324609C
(en)
|
1986-07-30 |
1993-11-23 |
Eastman Kodak Company |
Photographic element and process
|
|
JPS6427257U
(sr)
|
1987-08-11 |
1989-02-16 |
|
|
|
US4861701A
(en)
|
1987-10-05 |
1989-08-29 |
Eastman Kodak Company |
Photographic element and process comprising a compound which comprises two timing groups in sequence
|
|
AT388372B
(de)
|
1987-10-08 |
1989-06-12 |
Tanabe Seiyaku Co |
Neue naphthalinderivate und sie enthaltende pharmazeutika
|
|
JPH01250316A
(ja)
|
1987-12-28 |
1989-10-05 |
Tanabe Seiyaku Co Ltd |
抗脂血剤
|
|
WO1989008113A1
(fr)
|
1988-03-02 |
1989-09-08 |
Yoshitomi Pharmaceutical Industries, Ltd. |
COMPOSES DE 3,4-DIHYDROTHIENO[2,3-d]PYRIMIDINE ET LEURS APPLICATIONS PHARMACOLOGIQUES
|
|
US5208250A
(en)
|
1988-05-25 |
1993-05-04 |
Warner-Lambert Company |
Known and selected novel arylmethylenyl derivatives of thiazolidinones, imidazolidinones and oxazolidinones useful as antiallergy agents and anti-inflammatory agents
|
|
JPH054831Y2
(sr)
|
1988-11-22 |
1993-02-08 |
|
|
|
EP0482208B1
(en)
|
1990-04-25 |
2000-07-19 |
Nissan Chemical Industries Ltd. |
Pyridazinone derivative
|
|
SU1712359A1
(ru)
|
1990-05-07 |
1992-02-15 |
Уфимский Нефтяной Институт |
Гидрохлорид 8 @ -гидроксихинолинового эфира 8-гидроксихинолин-7-карбоновой кислоты, в качестве бактерицида дл подавлени сульфатвосстанавливающих бактерий и культур РSеUDомоNаS и АRтнRовастеR
|
|
EP0464612B1
(en)
|
1990-06-28 |
1998-05-13 |
Fuji Photo Film Co., Ltd. |
Silver halide photographic materials
|
|
EP0481614A1
(en)
|
1990-10-01 |
1992-04-22 |
Merck & Co. Inc. |
Substituted pyridopyrimidinones and related heterocycles as angiotensin II antagonists
|
|
JPH04190232A
(ja)
|
1990-11-26 |
1992-07-08 |
Fuji Photo Film Co Ltd |
ハロゲン化銀カラー写真感光材料
|
|
US5480883A
(en)
|
1991-05-10 |
1996-01-02 |
Rhone-Poulenc Rorer Pharmaceuticals Inc. |
Bis mono- and bicyclic aryl and heteroaryl compounds which inhibit EGF and/or PDGF receptor tyrosine kinase
|
|
IL101860A0
(en)
|
1991-05-31 |
1992-12-30 |
Ici Plc |
Heterocyclic derivatives
|
|
JP3108483B2
(ja)
|
1991-09-30 |
2000-11-13 |
日清製粉株式会社 |
インドール誘導体およびこれを有効成分とする抗潰瘍薬
|
|
HUT64064A
(en)
|
1992-02-13 |
1993-11-29 |
Chinoin Gyogyszer Es Vegyeszet |
Process for producing puyrido/1,2-a/pyrimidine derivatives and pharmaceutical compositions comprising same as active ingredient
|
|
US5521184A
(en)
|
1992-04-03 |
1996-05-28 |
Ciba-Geigy Corporation |
Pyrimidine derivatives and processes for the preparation thereof
|
|
WO1993022291A1
(en)
|
1992-04-24 |
1993-11-11 |
E.I. Du Pont De Nemours And Company |
Arthropodicidal and fungicidal aminopyrimidines
|
|
TW229140B
(sr)
|
1992-06-05 |
1994-09-01 |
Shell Internat Res Schappej B V |
|
|
FR2714907B1
(fr)
|
1994-01-07 |
1996-03-29 |
Union Pharma Scient Appl |
Nouveaux dérivés de l'Adénosine, leurs procédés de préparation, compositions pharmaceutiques les contenant.
|
|
US6342501B1
(en)
|
1994-02-25 |
2002-01-29 |
The Regents Of The University Of Michigan |
Pyrrolo[2,3-d] pyrimidines as antiviral agents
|
|
JPH0987282A
(ja)
|
1995-09-21 |
1997-03-31 |
Kyowa Hakko Kogyo Co Ltd |
チアゾール誘導体
|
|
JPH09176162A
(ja)
|
1995-12-22 |
1997-07-08 |
Toubishi Yakuhin Kogyo Kk |
チアゾリジンジオン誘導体及びその製造法並びにそれを含む医薬組成物
|
|
JPH09176116A
(ja)
|
1995-12-27 |
1997-07-08 |
Toray Ind Inc |
複素環誘導体およびその医薬用途
|
|
JPH1025294A
(ja)
|
1996-03-26 |
1998-01-27 |
Akira Matsuda |
縮合ヘテロ環誘導体、その製造法及びそれを含有する悪性腫瘍治療剤
|
|
WO1997048697A1
(en)
|
1996-06-19 |
1997-12-24 |
Rhone-Poulenc Rorer Limited |
Substituted azabicylic compounds and their use as inhibitors of the production of tnf and cyclic amp phosphodiesterase
|
|
WO1998001448A1
(fr)
|
1996-07-03 |
1998-01-15 |
Japan Energy Corporation |
Nouveaux derives de purine
|
|
US5866702A
(en)
|
1996-08-02 |
1999-02-02 |
Cv Therapeutics, Incorporation |
Purine inhibitors of cyclin dependent kinase 2
|
|
US6630496B1
(en)
|
1996-08-26 |
2003-10-07 |
Genetics Institute Llc |
Inhibitors of phospholipase enzymes
|
|
JPH10231297A
(ja)
|
1997-02-20 |
1998-09-02 |
Japan Energy Corp |
新規なアデニン−１−ｎ−オキシド誘導体およびその医薬用途
|
|
CA2309350C
(en)
|
1997-11-12 |
2007-04-03 |
Mitsubishi Chemical Corporation |
Purine derivatives and medicaments comprising the same as active ingredient
|
|
TW572758B
(en)
|
1997-12-22 |
2004-01-21 |
Sumitomo Pharma |
Type 2 helper T cell-selective immune response inhibitors comprising purine derivatives
|
|
WO2000010996A1
(en)
|
1998-08-25 |
2000-03-02 |
The Uab Research Foundation |
Inhibitors of bacterial nad synthetase
|
|
US6828344B1
(en)
|
1998-02-25 |
2004-12-07 |
Genetics Institute, Llc |
Inhibitors of phospholipase enzymes
|
|
BR9908280A
(pt)
|
1998-02-25 |
2000-10-31 |
Genetics Inst |
Inibidores de enzimas de fosfolipase
|
|
EA200000873A1
(ru)
|
1998-02-25 |
2001-04-23 |
Дженетикс Инститьют, Инк. |
Ингибиторы фосфолипазы a
|
|
US6479487B1
(en)
|
1998-02-26 |
2002-11-12 |
Aventis Pharmaceuticals Inc. |
6, 9-disubstituted 2-[trans-(4-aminocyclohexyl)amino] purines
|
|
CA2330756C
(en)
|
1998-05-04 |
2007-10-02 |
Asta Medica Aktiengesellschaft |
Indole derivatives and their use for the treatment of malignant and other diseases based on pathological cell proliferation
|
|
DE69942801D1
(de)
|
1998-05-26 |
2010-11-11 |
Chugai Pharmaceutical Co Ltd |
Heterozyklische indolderivate und mono- oder diazaindol-derivate
|
|
JP3997651B2
(ja)
|
1998-06-24 |
2007-10-24 |
コニカミノルタホールディングス株式会社 |
新規色素及び画像記録材料及び感熱転写材料及びインクジェット記録液
|
|
CA2339961C
(en)
|
1998-08-11 |
2009-01-20 |
Novartis Ag |
Isoquinoline derivatives with angiogenesis inhibiting activity
|
|
US6133031A
(en)
|
1999-08-19 |
2000-10-17 |
Isis Pharmaceuticals Inc. |
Antisense inhibition of focal adhesion kinase expression
|
|
ATE306487T1
(de)
|
1999-02-01 |
2005-10-15 |
Cv Therapeutics Inc |
Purinhemmer von cyclinabhängiger kinase 2 und ikb-alpha
|
|
GB9905075D0
(en)
|
1999-03-06 |
1999-04-28 |
Zeneca Ltd |
Chemical compounds
|
|
JP2000281654A
(ja)
|
1999-03-26 |
2000-10-10 |
Tanabe Seiyaku Co Ltd |
イソキノリン誘導体
|
|
DE19932571A1
(de)
|
1999-07-13 |
2001-01-18 |
Clariant Gmbh |
Verfahren zur Herstellung von Biarylen unter Palladophosphacyclobutan-Katalyse
|
|
JP2001151771A
(ja)
|
1999-09-10 |
2001-06-05 |
Kyowa Hakko Kogyo Co Ltd |
含窒素芳香族複素環誘導体
|
|
GB0004890D0
(en)
|
2000-03-01 |
2000-04-19 |
Astrazeneca Uk Ltd |
Chemical compounds
|
|
US6436965B1
(en)
|
2000-03-02 |
2002-08-20 |
Merck Frosst Canada & Co. |
PDE IV inhibiting amides, compositions and methods of treatment
|
|
EP1138328A1
(en)
|
2000-03-29 |
2001-10-04 |
Eli Lilly And Company Limited |
Naphthalene derivatives as CNS drugs
|
|
US6667300B2
(en)
|
2000-04-25 |
2003-12-23 |
Icos Corporation |
Inhibitors of human phosphatidylinositol 3-kinase delta
|
|
NZ522783A
(en)
|
2000-06-28 |
2004-07-30 |
Smithkline Beecham P |
Wet milling process for pharmaceuticals with agitator or chamber having nylon with internal lubricant
|
|
CN1331340A
(zh)
|
2000-06-30 |
2002-01-16 |
上海博德基因开发有限公司 |
一种新的多肽——人拓扑异构酶12.1和编码这种多肽的多核苷酸
|
|
WO2002002533A1
(fr)
|
2000-07-05 |
2002-01-10 |
Yamanouchi Pharmaceutical Co., Ltd. |
Derives de propane-1,3-dione
|
|
FR2814073B1
(fr)
|
2000-09-21 |
2005-06-24 |
Yang Ji Chemical Company Ltd |
Composition pharmaceutique antifongique et/ou antiparasitaire et nouveaux derives de l'indole a titre de principes actifs d'une telle composition
|
|
DOP2002000334A
(es)
|
2001-02-14 |
2002-08-30 |
Warner Lambert Co |
Pirimidinas biciclicas como inhibidores de metaloproteinasas de matriz
|
|
SE0100568D0
(sv)
|
2001-02-20 |
2001-02-20 |
Astrazeneca Ab |
Compounds
|
|
HUP0400175A2
(en)
|
2001-03-01 |
2007-07-30 |
Shionogi & Co |
Nitrogen-containing heteroaryl compounds having hiv integrase inhibitory activity, their use and pharmaceutical compositions containing them
|
|
UA76977C2
(en)
|
2001-03-02 |
2006-10-16 |
Icos Corp |
Aryl- and heteroaryl substituted chk1 inhibitors and their use as radiosensitizers and chemosensitizers
|
|
WO2002078701A1
(en)
|
2001-03-30 |
2002-10-10 |
Smithkline Beecham Corporation |
Use of pyrazolopyridines as therapeutic compounds
|
|
JP4237497B2
(ja)
|
2001-03-30 |
2009-03-11 |
スミスクライン ビーチャム コーポレーション |
ピラゾロピリジン類、その調製方法及びその治療用化合物としての使用
|
|
DE60204452T2
(de)
|
2001-04-27 |
2005-12-15 |
Smithkline Beecham Corp. |
Pyrazolo[1,5a]Pyridinderivate
|
|
CZ294535B6
(cs)
|
2001-08-02 |
2005-01-12 |
Ústav Experimentální Botaniky Avčr |
Heterocyklické sloučeniny na bázi N6-substituovaného adeninu, způsoby jejich přípravy, jejich použití pro přípravu léčiv, kosmetických přípravků a růstových regulátorů, farmaceutické přípravky, kosmetické přípravky a růstové regulátory tyto sloučeniny obsahující
|
|
GB0121033D0
(en)
|
2001-08-30 |
2001-10-24 |
Novartis Ag |
Organic compounds
|
|
US8124625B2
(en)
|
2001-09-14 |
2012-02-28 |
Shionogi & Co., Ltd. |
Method of enhancing the expression of apolipoprotein AI using olefin derivatives
|
|
AU2002337142B2
(en)
|
2001-09-19 |
2007-10-11 |
Aventis Pharma S.A. |
Indolizines as kinase protein inhibitors
|
|
RU2004112787A
(ru)
|
2001-09-26 |
2005-10-10 |
Байер Фармасьютикалс Корпорейшн (US) |
Производные 1,6-нафтиридина как противодиабетические средства
|
|
DE60228103D1
(de)
|
2001-10-02 |
2008-09-18 |
Smithkline Beecham Corp |
Chemische verbindungen
|
|
WO2003037347A1
(en)
|
2001-10-30 |
2003-05-08 |
Novartis Ag |
Staurosporine derivatives as inhibitors of flt3 receptor tyrosine kinase activity
|
|
US7262164B2
(en)
|
2001-11-09 |
2007-08-28 |
Enzon, Inc. |
Polymeric thiol-linked prodrugs employing benzyl elimination systems
|
|
EP1314733A1
(en)
|
2001-11-22 |
2003-05-28 |
Aventis Pharma Deutschland GmbH |
Indole-2-carboxamides as factor Xa inhibitors
|
|
AU2002357043B2
(en)
|
2001-12-06 |
2008-04-24 |
Merck Sharp & Dohme Corp. |
Mitotic kinesin inhibitors
|
|
ES2291543T3
(es)
|
2001-12-06 |
2008-03-01 |
MERCK & CO., INC. |
Inhibicion de kinesina mitotica.
|
|
TW200301135A
(en)
|
2001-12-27 |
2003-07-01 |
Otsuka Maryland Res Inst Inc |
Pharmaceutical compositions comprising a multifunctional phosphodiesterase inhibitor and an adenosine uptake inhibitor
|
|
CA2476162A1
(en)
|
2002-02-13 |
2003-08-21 |
Takeda Chemical Industries, Ltd. |
Jnk inhibitor
|
|
US20050049267A1
(en)
|
2002-03-01 |
2005-03-03 |
Pintex Pharmaceuticals, Inc. |
Pin1-modulating compounds and methods of use thereof
|
|
DE60315615T2
(de)
|
2002-04-03 |
2008-10-02 |
Bristol-Myers Squibb Co. |
Tricyclische verbindungen basierend auf thiophen und arzneimittel, die diese umfassen
|
|
WO2003093290A2
(en)
|
2002-05-06 |
2003-11-13 |
Genelabs Technologies, Inc. |
Nucleoside derivatives for treating hepatitis c virus infection
|
|
TW200406374A
(en)
|
2002-05-29 |
2004-05-01 |
Novartis Ag |
Diaryl urea derivatives useful for the treatment of protein kinase dependent diseases
|
|
GB0215676D0
(en)
|
2002-07-05 |
2002-08-14 |
Novartis Ag |
Organic compounds
|
|
DE60322920D1
(de)
|
2002-08-13 |
2008-09-25 |
Shionogi & Co |
Heterocyclische verbindungen mit hiv-integrase-hemmender wirkung
|
|
JP4190232B2
(ja)
|
2002-08-26 |
2008-12-03 |
富士通株式会社 |
機械研磨を行う方法
|
|
MXPA05003193A
(es)
|
2002-09-27 |
2005-06-08 |
Sumitomo Pharma |
Compuesto de adenina novedoso y uso del mismo.
|
|
US7138402B2
(en)
|
2003-09-18 |
2006-11-21 |
Conforma Therapeutics Corporation |
Pyrrolopyrimidines and related analogs as HSP90-inhibitors
|
|
TWI335913B
(en)
|
2002-11-15 |
2011-01-11 |
Vertex Pharma |
Diaminotriazoles useful as inhibitors of protein kinases
|
|
DK2316831T3
(da)
|
2002-11-21 |
2013-06-10 |
Novartis Ag |
2-(Morpholin-4-yl)pyrimidiner som phosphotidylinositol (PI)-3-kinaseinhibitorer samt deres anvendelse ved behandling af cancer
|
|
EP1568688B1
(en)
|
2002-11-25 |
2011-08-31 |
Mochida Pharmaceutical Co., Ltd. |
Therapeutic agent for respiratory disease containing 4-hydroxypiperidine derivative as active ingredient
|
|
UA80767C2
(en)
|
2002-12-20 |
2007-10-25 |
Pfizer Prod Inc |
Pyrimidine derivatives for the treatment of abnormal cell growth
|
|
AU2003292625B2
(en)
|
2002-12-26 |
2008-07-24 |
Eisai R & D Management Co., Ltd. |
Selective estrogen receptor modulators
|
|
CZ294538B6
(cs)
|
2002-12-30 |
2005-01-12 |
Ústav Experimentální Botaniky Akademie Vědčeské Re |
Substituční deriváty N6-benzyladenosinu, způsob jejich přípravy, jejich použití pro přípravu léčiv, kosmetických přípravků a růstových regulátorů, farmaceutické přípravky, kosmetické přípravky a růstové regulátory tyto sloučeniny obsahující
|
|
RU2233842C1
(ru)
|
2003-01-13 |
2004-08-10 |
Петров Владимир Иванович |
Производные пурина, обладающие противовирусной активностью
|
|
PE20050068A1
(es)
|
2003-02-06 |
2005-03-11 |
Novartis Ag |
2-cianopirrolopirimidinas como inhibidores de la catepsina s
|
|
GB0304640D0
(en)
|
2003-02-28 |
2003-04-02 |
Novartis Ag |
Organic compounds
|
|
GB0305929D0
(en)
|
2003-03-14 |
2003-04-23 |
Novartis Ag |
Organic compounds
|
|
SE0300908D0
(sv)
|
2003-03-31 |
2003-03-31 |
Astrazeneca Ab |
Azaindole derivatives, preparations thereof, uses thereof and compositions containing them
|
|
US7129264B2
(en)
|
2003-04-16 |
2006-10-31 |
Bristol-Myers Squibb Company |
Biarylmethyl indolines and indoles as antithromboembolic agents
|
|
US20060247245A1
(en)
|
2003-05-05 |
2006-11-02 |
Yuelian Xu |
Substituted imidazolopyrazine and triazolopyrazine derivatives: gabaa receptor ligands
|
|
US7326711B2
(en)
|
2003-06-20 |
2008-02-05 |
Chiron Corporation |
Pyridino[1,2-a]pyrimidin-4-one compounds as anticancer agents
|
|
WO2005000309A2
(en)
|
2003-06-27 |
2005-01-06 |
Ionix Pharmaceuticals Limited |
Chemical compounds
|
|
JP4570015B2
(ja)
|
2003-07-14 |
2010-10-27 |
クミアイ化学工業株式会社 |
２−イソオキサゾリン誘導体及びそれを有効成分として含有する除草剤
|
|
SG145748A1
(en)
|
2003-08-15 |
2008-09-29 |
Irm Llc |
6-substituted anilino purines as rtk inhibitors
|
|
CN1856474A
(zh)
|
2003-09-23 |
2006-11-01 |
默克公司 |
异喹啉钾通道抑制剂
|
|
PE20050952A1
(es)
|
2003-09-24 |
2005-12-19 |
Novartis Ag |
Derivados de isoquinolina como inhibidores de b-raf
|
|
EP1730148A4
(en)
|
2004-02-03 |
2009-08-19 |
Abbott Lab |
USE OF AMINOBENZOXAZOLES AS THERAPEUTIC AGENTS
|
|
US20070191395A1
(en)
|
2004-02-16 |
2007-08-16 |
Katsuhiro Kawakami |
Heterocyclic compounds having antifungal activity
|
|
CN1560035A
(zh)
|
2004-03-12 |
2005-01-05 |
沈阳药科大学 |
5－羟基吲哚－3－羧酸脂类衍生物
|
|
WO2005091857A2
(en)
|
2004-03-12 |
2005-10-06 |
Bayer Pharmaceuticals Corporation |
1,6-naphthyridine and 1,8-naphthyridine derivatives and their use to treat diabetes and related disorders
|
|
JPWO2005092892A1
(ja)
|
2004-03-26 |
2008-02-14 |
大日本住友製薬株式会社 |
８−オキソアデニン化合物
|
|
JP2007531729A
(ja)
|
2004-04-02 |
2007-11-08 |
アデノシン、セラピューティックス、リミテッド、ライアビリティ、カンパニー |
Ａ２ａアデノシンレセプターの選択的アンタゴニスト
|
|
WO2005113554A2
(en)
|
2004-05-13 |
2005-12-01 |
Icos Corporation |
Method of preparing 3-phenyl-2-[9h-purin-6-ylamino)-methyl]-3h-quinazolin-4-one and substituted and related compounds
|
|
WO2005110410A2
(en)
|
2004-05-14 |
2005-11-24 |
Abbott Laboratories |
Kinase inhibitors as therapeutic agents
|
|
MX2007000809A
(es)
|
2004-07-22 |
2007-03-21 |
Astrazeneca Ab |
Pirimidonas fusionadas utiles en el tratamiento y la prevencion de cancer.
|
|
RU2447077C2
(ru)
|
2004-08-18 |
2012-04-10 |
Астразенека Аб |
Энантиомеры выбранных конденсированных пиримидинов и их применение для лечения и предотвращения злокачественного новообразования
|
|
DE102004044221A1
(de)
|
2004-09-14 |
2006-03-16 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Neue 3-Methyl-7-butinyl-xanthine, deren Herstellung und deren Verwendung als Arzneimittel
|
|
GB0420719D0
(en)
|
2004-09-17 |
2004-10-20 |
Addex Pharmaceuticals Sa |
Novel allosteric modulators
|
|
CA2584979A1
(en)
|
2004-10-19 |
2006-05-11 |
Novartis Vaccines And Diagnostics, Inc. |
Indole and benzimidazole derivatives
|
|
EP1807417A2
(en)
|
2004-11-04 |
2007-07-18 |
Neurogen Corporation |
Pyrazolylmethyl heteroaryl derivatives
|
|
US9512125B2
(en)
|
2004-11-19 |
2016-12-06 |
The Regents Of The University Of California |
Substituted pyrazolo[3.4-D] pyrimidines as anti-inflammatory agents
|
|
CA2586605A1
(en)
|
2004-11-24 |
2006-06-01 |
Novartis Ag |
Combinations of jak inhibitors and at least one of bcr-abl, flt-3, fak or raf kinase inhibitors
|
|
US20080287469A1
(en)
|
2005-02-17 |
2008-11-20 |
Diacovo Thomas G |
Phosphoinositide 3-Kinase Inhibitors for Inhibiting Leukocyte Accumulation
|
|
WO2007002701A2
(en)
|
2005-06-27 |
2007-01-04 |
Amgen Inc. |
Anti-inflammatory aryl nitrile compounds
|
|
FR2889192A1
(fr)
|
2005-07-27 |
2007-02-02 |
Cytomics Systems Sa |
Composes antifongiques, compositions contenant ces composes et leurs utilisations
|
|
CN101309690A
(zh)
|
2005-08-16 |
2008-11-19 |
阿诺麦德股份有限公司 |
趋化因子受体结合化合物
|
|
US7642270B2
(en)
|
2005-09-14 |
2010-01-05 |
Janssen Pharmaceutica N.V. |
5-oxo-5,8-dihydro-pyrido-pyrimidine as inhibitors of c-fms kinase
|
|
US20090118263A1
(en)
|
2005-09-22 |
2009-05-07 |
Dainippon Sumitomo Pharma Co., Ltd. |
Novel Adenine Compound
|
|
GB0520657D0
(en)
|
2005-10-11 |
2005-11-16 |
Ludwig Inst Cancer Res |
Pharmaceutical compounds
|
|
WO2007053452A1
(en)
|
2005-11-01 |
2007-05-10 |
Targegen, Inc. |
Bi-aryl meta-pyrimidine inhibitors of kinases
|
|
EP1783114A1
(en)
|
2005-11-03 |
2007-05-09 |
Novartis AG |
N-(hetero)aryl indole derivatives as pesticides
|
|
WO2007059108A2
(en)
|
2005-11-10 |
2007-05-24 |
Chemocentryx, Inc. |
Substituted quinolones and methods of use
|
|
EP2426129B1
(en)
|
2005-12-13 |
2016-11-02 |
Incyte Holdings Corporation |
Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as Janus kinase inhibitors
|
|
US7989461B2
(en)
|
2005-12-23 |
2011-08-02 |
Amgen Inc. |
Substituted quinazolinamine compounds for the treatment of cancer
|
|
JP2009524689A
(ja)
|
2006-01-25 |
2009-07-02 |
スミスクライン ビーチャム コーポレーション |
化合物
|
|
UY30118A1
(es)
|
2006-01-31 |
2007-06-29 |
Tanabe Seiyaku Co |
Compueto amina trisustituido
|
|
PE20070978A1
(es)
|
2006-02-14 |
2007-11-15 |
Novartis Ag |
COMPUESTOS HETEROCICLICOS COMO INHIBIDORES DE FOSFATIDILINOSITOL 3-QUINASAS (PI3Ks)
|
|
US20090069304A1
(en)
|
2006-03-03 |
2009-03-12 |
Shionogi & Co., Ltd. |
Mmp-13 selective inhibitor
|
|
EP2007373A4
(en)
|
2006-03-29 |
2012-12-19 |
Foldrx Pharmaceuticals Inc |
INHIBITION OF ALPHA SYNUCLEINE TOXICITY
|
|
AU2007347115A1
(en)
|
2006-04-04 |
2008-10-23 |
The Regents Of The University Of California |
PI3 kinase antagonists
|
|
CA2656067C
(en)
|
2006-06-23 |
2014-08-12 |
Radius Health, Inc. |
Treatment of vasomotor symptoms with selective estrogen receptor modulators
|
|
WO2008005303A2
(en)
|
2006-06-30 |
2008-01-10 |
Janssen Pharmaceutica N.V. |
Thiazolopyrimidine modulators of trpv1
|
|
US20080009508A1
(en)
|
2006-07-10 |
2008-01-10 |
Lucie Szucova |
6,9-Disubstituted Purine Derivatives And Their Use For Treating Skin
|
|
EP2046788A1
(en)
|
2006-07-12 |
2009-04-15 |
Syngeta Participations AG |
Triazolopyridine derivatives as herbicides
|
|
NZ575274A
(en)
|
2006-08-08 |
2010-11-26 |
Chugai Pharmaceutical Co Ltd |
Pyrimidine derivative as pi3k inhibitor and use thereof
|
|
WO2008025821A1
(en)
|
2006-08-30 |
2008-03-06 |
Cellzome Limited |
Triazole derivatives as kinase inhibitors
|
|
WO2008032033A1
(en)
|
2006-09-14 |
2008-03-20 |
Astrazeneca Ab |
4-benzimidazolyl-2-morpholino-6-piperazinylpyrimidine derivatives as pi3k and mtor inhibitors for the treatment of proliferative disorders
|
|
EP1972631A1
(en)
|
2007-03-23 |
2008-09-24 |
Novartis AG |
Imidazopyridazines as PI3K lipid kinase inhibitors
|
|
US20080114007A1
(en)
|
2006-10-31 |
2008-05-15 |
Player Mark R |
5-oxo-5,8-dihydro-pyrido-pyrimidines as inhibitors of c-fms kinase
|
|
KR20090087027A
(ko)
|
2006-11-13 |
2009-08-14 |
일라이 릴리 앤드 캄파니 |
염증 질환 및 암의 치료를 위한 티에노피리미디논
|
|
EP3443958A1
(en)
|
2006-11-22 |
2019-02-20 |
Incyte Holdings Corporation |
Imidazotriazines and imidazopyrimidines as kinase inhibitors
|
|
CA2672960A1
(en)
|
2006-12-20 |
2008-07-10 |
Schering Corporation |
Novel jnk inhibitors
|
|
MX2009006921A
(es)
|
2006-12-29 |
2009-07-06 |
Hoffmann La Roche |
Derivados azaespiro.
|
|
RU2009133336A
(ru)
|
2007-02-05 |
2011-03-20 |
Ксенон Фармасьютикалз Инк. (Ca) |
Пиридопиримидиноновые соединения, применимые при лечении заболеваний или состояний, опосредуемых натриевыми каналами
|
|
AU2008216382A1
(en)
|
2007-02-12 |
2008-08-21 |
Array Biopharma, Inc. |
Novel inhibitors hepatitis C virus replication
|
|
PE20081887A1
(es)
|
2007-03-20 |
2009-01-16 |
Dainippon Sumitomo Pharma Co |
Nuevo compuesto de adenina
|
|
US20080233127A1
(en)
|
2007-03-21 |
2008-09-25 |
Wyeth |
Imidazolopyrimidine analogs and their use as pi3 kinase and mtor inhibitors
|
|
MX2009009968A
(es)
|
2007-03-23 |
2009-10-08 |
Amgen Inc |
Compuestos heterociclicos y sus usos.
|
|
EP2132207A2
(en)
|
2007-03-23 |
2009-12-16 |
Amgen Inc. |
Heterocyclic compounds and their uses
|
|
US8039505B2
(en)
|
2007-04-11 |
2011-10-18 |
University Of Utah Research Foundation |
Compounds for modulating T-cells
|
|
US8633186B2
(en)
|
2007-06-08 |
2014-01-21 |
Senomyx Inc. |
Modulation of chemosensory receptors and ligands associated therewith
|
|
US9603848B2
(en)
|
2007-06-08 |
2017-03-28 |
Senomyx, Inc. |
Modulation of chemosensory receptors and ligands associated therewith
|
|
JP2010531304A
(ja)
|
2007-06-18 |
2010-09-24 |
ユニバーシティ オブ ルイビル リサーチ ファウンデーション、インコーポレイテッド |
抗悪性腫瘍活性を有するｐｆｋｆｂ３阻害物質ファミリー
|
|
EP2170888B1
(en)
|
2007-06-29 |
2015-04-22 |
Gilead Sciences, Inc. |
Purine derivatives and their use as modulators of toll-like receptor 7
|
|
WO2009042294A2
(en)
|
2007-08-10 |
2009-04-02 |
Burnham Institute For Medical Research |
Tissue-nonspecific alkaline phosphatase (tnap) activators and uses thereof
|
|
JP2009076865A
(ja)
|
2007-08-29 |
2009-04-09 |
Fujifilm Corp |
有機電界発光素子
|
|
WO2009026701A1
(en)
|
2007-08-29 |
2009-03-05 |
Methylgene Inc. |
Sirtuin inhibitors
|
|
WO2009034386A1
(en)
|
2007-09-13 |
2009-03-19 |
Astrazeneca Ab |
Derivatives of adenine and 8-aza-adenine and uses thereof-796
|
|
JP2009080233A
(ja)
|
2007-09-26 |
2009-04-16 |
Kyocera Mita Corp |
電子写真感光体
|
|
CZ300774B6
(cs)
|
2007-10-05 |
2009-08-05 |
Univerzita Palackého |
Substituované 6-(alkylbenzylamino)purinové deriváty pro použití jako antagonisté cytokininových receptoru a prípravky obsahující tyto slouceniny
|
|
WO2009062118A2
(en)
|
2007-11-07 |
2009-05-14 |
Foldrx Pharmaceuticals, Inc. |
Modulation of protein trafficking
|
|
WO2009063235A1
(en)
|
2007-11-13 |
2009-05-22 |
Astrazeneca Ab |
Derivatives of 1,9-dihydro-6h-purin-6-one and uses thereof-018
|
|
JP2009120686A
(ja)
|
2007-11-14 |
2009-06-04 |
Toyo Ink Mfg Co Ltd |
光重合開始剤、重合性組成物、および重合物の製造方法。
|
|
US7820665B2
(en)
|
2007-12-19 |
2010-10-26 |
Amgen Inc. |
Imidazopyridazine inhibitors of PI3 kinase for cancer treatment
|
|
US20110112135A1
(en)
|
2007-12-21 |
2011-05-12 |
Singhaus Jr Robert Ray |
Imidazo [1,2-A] Pyridine Compounds
|
|
WO2009086303A2
(en)
|
2007-12-21 |
2009-07-09 |
University Of Rochester |
Method for altering the lifespan of eukaryotic organisms
|
|
US8399483B2
(en)
|
2007-12-21 |
2013-03-19 |
Ucb Pharma S.A. |
Quinoxaline and quinoline derivatives as kinase inhibitors
|
|
US7960397B2
(en)
|
2007-12-28 |
2011-06-14 |
Institute Of Experimental Botany, Academy Of Sciences Of The Czech Republic |
6,9-disubstituted purine derivatives and their use as cosmetics and cosmetic compositions
|
|
BRPI0722222A2
(pt)
|
2007-12-28 |
2015-06-16 |
Topharman Shangai Co Ltd |
N-{1-[3-(2-etóxi-5-(4-etilpiperazinil)sulfonilfenil)-4,5-di hidro-5-oxo-1,2,4-triazina-6-il]etil}butiramida, seu método de preparo e seu uso
|
|
US8193182B2
(en)
|
2008-01-04 |
2012-06-05 |
Intellikine, Inc. |
Substituted isoquinolin-1(2H)-ones, and methods of use thereof
|
|
WO2009098715A2
(en)
|
2008-01-11 |
2009-08-13 |
Natco Pharma Limited |
Novel pyrazolo [3, 4 -d] pyrimidine derivatives as anti -cancer agents
|
|
US9089572B2
(en)
|
2008-01-17 |
2015-07-28 |
California Institute Of Technology |
Inhibitors of p97
|
|
US8987280B2
(en)
|
2008-01-30 |
2015-03-24 |
Genentech, Inc. |
Pyrazolopyrimidine PI3K inhibitor compounds and methods of use
|
|
JPWO2009128520A1
(ja)
|
2008-04-18 |
2011-08-04 |
塩野義製薬株式会社 |
Ｐｉ３ｋ阻害活性を有する複素環化合物
|
|
US8119647B2
(en)
|
2008-04-23 |
2012-02-21 |
Glenmark Pharmaceuticals S.A. |
Fused pyrimidineone compounds as TRPV3 modulators
|
|
WO2009140215A2
(en)
|
2008-05-11 |
2009-11-19 |
Geraghty, Erin |
Method for treating drug-resistant bacterial and other infections with clioquinol, phanquinone, and related compounds
|
|
EP2300005A4
(en)
|
2008-05-28 |
2011-07-13 |
Us Of America As Represented By The Secretary Of The Army On Behalf Of U S Army Medical Res And Mate |
Small-molecule inhibitors of botulinum neurotoxins
|
|
AU2009271414A1
(en)
|
2008-06-20 |
2010-01-21 |
Metabolex, Inc. |
Aryl GPR119 agonists and uses thereof
|
|
US8026271B2
(en)
|
2008-07-11 |
2011-09-27 |
National Health Research Institutes |
Formulations of indol-3-yl-2-oxoacetamide compounds
|
|
WO2010018458A2
(en)
|
2008-08-12 |
2010-02-18 |
Crystalgenomics, Inc. |
Phenol derivatives and methods of use thereof
|
|
JP5731978B2
(ja)
|
2008-09-26 |
2015-06-10 |
インテリカイン， エルエルシー |
複素環キナーゼ阻害剤
|
|
US20100202963A1
(en)
|
2008-11-13 |
2010-08-12 |
Gallatin W Michael |
Therapies for hematologic malignancies
|
|
US20110245209A1
(en)
|
2008-12-16 |
2011-10-06 |
Schering Corporation |
Pyridopyrimidine derivatives and methods of use thereof
|
|
AR075111A1
(es)
|
2008-12-24 |
2011-03-09 |
Bial Portela & Ca Sa |
Derivados heterociclicos de diazoles y triazoles, composiciones farmaceuticas que los contienen y uso de los mismos para el tratamiento de trastornos del metabolismo y del sistema nervioso, entre otros.
|
|
US8563579B2
(en)
|
2009-01-15 |
2013-10-22 |
Anvyl Llc |
α-7 nicotinic acetylcholine receptor allosteric modulators, their derivatives and uses thereof
|
|
ES2598358T3
(es)
|
2009-02-13 |
2017-01-27 |
Ucb Pharma, S.A. |
Derivados de quinolina como inhibidores de PI3K quinasa
|
|
US8497276B2
(en)
|
2009-03-31 |
2013-07-30 |
Arqule, Inc. |
Substituted indolo-piperidine compounds
|
|
WO2010118367A2
(en)
|
2009-04-10 |
2010-10-14 |
Progenics Pharmaceuticals, Inc. |
Antiviral pyrimidines
|
|
US8546409B2
(en)
|
2009-04-20 |
2013-10-01 |
Gilead Calistoga Llc |
Methods of treatment for solid tumors
|
|
WO2010127208A1
(en)
|
2009-04-30 |
2010-11-04 |
Forest Laboratories Holdings Limited |
Inhibitors of acetyl-coa carboxylase
|
|
JP5789252B2
(ja)
|
2009-05-07 |
2015-10-07 |
インテリカイン， エルエルシー |
複素環式化合物およびその使用
|
|
WO2010135650A1
(en)
|
2009-05-22 |
2010-11-25 |
Incyte Corporation |
N-(HETERO)ARYL-PYRROLIDINE DERIVATIVES OF PYRAZOL-4-YL-PYRROLO[2,3-d]PYRIMIDINES AND PYRROL-3-YL-PYRROLO[2,3-d]PYRIMIDINES AS JANUS KINASE INHIBITORS
|
|
TW201111362A
(en)
|
2009-06-25 |
2011-04-01 |
Amgen Inc |
Heterocyclic compounds and their uses
|
|
AU2010266064A1
(en)
|
2009-06-25 |
2012-01-19 |
Amgen Inc. |
4H - pyrido [1, 2 - a] pyrimidin - 4 - one derivatives as PI3 K inhibitors
|
|
AU2010273816B2
(en)
|
2009-06-29 |
2015-07-09 |
Incyte Holdings Corporation |
Pyrimidinones as PI3K inhibitors
|
|
RU2561132C2
(ru)
|
2009-06-29 |
2015-08-20 |
Аджиос Фармасьютикалз, Инк. |
Производные хинолинсульфонамидов и их применение для модулирования пкм2 активности
|
|
AR077252A1
(es)
|
2009-06-29 |
2011-08-10 |
Xenon Pharmaceuticals Inc |
Enantiomeros de compuestos de espirooxindol y sus usos como agentes terapeuticos
|
|
FR2947269B1
(fr)
|
2009-06-29 |
2013-01-18 |
Sanofi Aventis |
Nouveaux composes anticancereux
|
|
CN102647987A
(zh)
|
2009-07-21 |
2012-08-22 |
吉里德卡利斯托加公司 |
使用pi3k抑制剂治疗肝脏障碍
|
|
PT2470546E
(pt)
|
2009-08-28 |
2013-10-14 |
Takeda Pharmaceutical |
Compostos de hexa-hidrooxazinopteridina para serem utilizados como inibidores de mtor
|
|
US9249145B2
(en)
|
2009-09-01 |
2016-02-02 |
Incyte Holdings Corporation |
Heterocyclic derivatives of pyrazol-4-yl-pyrrolo[2,3-d]pyrimidines as janus kinase inhibitors
|
|
MX2012004020A
(es)
|
2009-10-20 |
2012-05-08 |
Cellzome Ltd |
Analogos de heterociclilo pirazolopirimidina como inhibidores de jak.
|
|
SI2491035T1
(sl)
|
2009-10-22 |
2017-10-30 |
Gilead Sciences, Inc. |
Derivati purina ali deazapurina uporabni za zdravljenje (med drugimi) virusnih okužb
|
|
SG10201500895XA
(en)
|
2009-11-05 |
2015-04-29 |
Rhizen Pharmaceuticals Sa |
Chromen-4-one Derivatives As Kinase Modulators
|
|
NZ599815A
(en)
|
2009-11-10 |
2013-04-26 |
Pfizer |
N1-pyrazolospiroketone acetyl-coa carboxylase inhibitors
|
|
WO2011058111A1
(en)
|
2009-11-12 |
2011-05-19 |
Ucb Pharma S.A. |
Aminopurine derivatives as kinase inhibitors
|
|
WO2011058113A1
(en)
|
2009-11-12 |
2011-05-19 |
Ucb Pharma S.A. |
Fused bicyclic pyridine and pyrazine derivatives as kinase inhibitors
|
|
EP2511283A4
(en)
|
2009-12-10 |
2013-07-03 |
Inst Materia Medica Cams |
N6-SUBSTITUTED ADENOSINE DERIVATIVES, N6-SUBSTITUTED ADENINE DERIVATIVES AND THEIR USE
|
|
TW201130842A
(en)
|
2009-12-18 |
2011-09-16 |
Incyte Corp |
Substituted fused aryl and heteroaryl derivatives as PI3K inhibitors
|
|
WO2011075643A1
(en)
|
2009-12-18 |
2011-06-23 |
Incyte Corporation |
Substituted heteroaryl fused derivatives as pi3k inhibitors
|
|
CA2784566A1
(en)
|
2009-12-18 |
2011-06-23 |
Amgen Inc. |
Heterocyclic compounds and their uses
|
|
JP2011136925A
(ja)
|
2009-12-28 |
2011-07-14 |
Dainippon Sumitomo Pharma Co Ltd |
含窒素二環性化合物
|
|
MX2012007954A
(es)
|
2010-01-07 |
2012-08-03 |
Dow Agrosciences Llc |
Tiazolo [5, 4-d] pirimidinas y su uso como agroquimicos.
|
|
US8633183B2
(en)
|
2010-01-26 |
2014-01-21 |
Boehringer Ingelheim International Gmbh |
5-alkynyl-pyrimidines
|
|
KR102354472B1
(ko)
|
2010-03-10 |
2022-01-21 |
인사이트 홀딩스 코포레이션 |
Ｊａｋ１ 저해제로서의 피페리딘４일 아제티딘 유도체
|
|
MA34075B1
(fr)
|
2010-03-22 |
2013-03-05 |
Glenmark Pharmaceuticals Sa |
Composition pharmaceutique comprenant un dérivé pyrimidineone
|
|
UY33304A
(es)
|
2010-04-02 |
2011-10-31 |
Amgen Inc |
Compuestos heterocíclicos y sus usos
|
|
EP2558463A1
(en)
|
2010-04-14 |
2013-02-20 |
Incyte Corporation |
Fused derivatives as i3 inhibitors
|
|
AU2011255218B2
(en)
|
2010-05-21 |
2015-03-12 |
Infinity Pharmaceuticals, Inc. |
Chemical compounds, compositions and methods for kinase modulation
|
|
JP2013528228A
(ja)
|
2010-06-11 |
2013-07-08 |
ギリアード カリストガ エルエルシー |
キナゾリノン化合物による選択した患者における血液系障害を処置する方法
|
|
WO2011163195A1
(en)
|
2010-06-21 |
2011-12-29 |
Incyte Corporation |
Fused pyrrole derivatives as pi3k inhibitors
|
|
AU2011272853A1
(en)
|
2010-07-01 |
2013-01-10 |
Amgen Inc. |
Heterocyclic compounds and their use as inhibitors of PI3K activity
|
|
AU2011271460B2
(en)
|
2010-07-01 |
2014-02-06 |
Amgen Inc. |
Heterocyclic compounds and their use as inhibitors of P13K activity
|
|
US20130096134A1
(en)
|
2010-07-02 |
2013-04-18 |
Amgen Inc. |
Heterocyclic compounds and their uses
|
|
EP2619209A1
(en)
|
2010-09-24 |
2013-07-31 |
Gilead Calistoga LLC |
Atropisomers of pi3k-inhibiting compounds
|
|
JP2013541591A
(ja)
|
2010-11-04 |
2013-11-14 |
アムジエン・インコーポレーテツド |
複素環化合物およびそれらの使用
|
|
WO2012064973A2
(en)
|
2010-11-10 |
2012-05-18 |
Infinity Pharmaceuticals, Inc. |
Heterocyclic compounds and uses thereof
|
|
MX2013005567A
(es)
|
2010-11-17 |
2013-10-30 |
Amgen Inc |
Derivados de quinolina como inhibidores de pik3.
|
|
TW201249845A
(en)
|
2010-11-19 |
2012-12-16 |
Incyte Corp |
Cyclobutyl substituted pyrrolopyridine and pyrrolopyrimidine derivatives as JAK inhibitors
|
|
CA2818545C
(en)
|
2010-11-19 |
2019-04-16 |
Incyte Corporation |
Heterocyclic-substituted pyrrolopyridines and pyrrolopyrimidines as jak inhibitors
|
|
WO2012080729A2
(en)
|
2010-12-14 |
2012-06-21 |
Electrophoretics Limited |
CASEIN KINASE 1δ (CK1δ) INHIBITORS
|
|
AR084366A1
(es)
|
2010-12-20 |
2013-05-08 |
Incyte Corp |
N-(1-(fenil sustituido)etil)-9h-purin-6-aminas como inhibidores de pi3k
|
|
MX2013007261A
(es)
|
2010-12-23 |
2013-11-04 |
Amgen Inc |
Compuestos heterociclicos y sus usos.
|
|
NZ612909A
(en)
|
2011-01-10 |
2015-09-25 |
Infinity Pharmaceuticals Inc |
Processes for preparing isoquinolinones and solid forms of isoquinolinones
|
|
USRE47009E1
(en)
|
2011-02-01 |
2018-08-28 |
The Children's Hospital Of Philadelphia |
HDAC inhibitors and therapeutic methods using the same
|
|
WO2012125629A1
(en)
|
2011-03-14 |
2012-09-20 |
Incyte Corporation |
Substituted diamino-pyrimidine and diamino-pyridine derivatives as pi3k inhibitors
|
|
US9126948B2
(en)
|
2011-03-25 |
2015-09-08 |
Incyte Holdings Corporation |
Pyrimidine-4,6-diamine derivatives as PI3K inhibitors
|
|
AR086983A1
(es)
|
2011-06-20 |
2014-02-05 |
Incyte Corp |
Derivados de azetidinil fenil, piridil o pirazinil carboxamida como inhibidores de jak
|
|
CN103930422A
(zh)
|
2011-07-19 |
2014-07-16 |
无限药品股份有限公司 |
杂环化合物及其用途
|
|
TW201313721A
(zh)
|
2011-08-18 |
2013-04-01 |
Incyte Corp |
作為ｊａｋ抑制劑之環己基氮雜環丁烷衍生物
|
|
PT3196202T
(pt)
|
2011-09-02 |
2019-05-31 |
Incyte Holdings Corp |
Heterociclilaminas como inibidores de pi3k
|
|
US20140235643A1
(en)
|
2011-10-04 |
2014-08-21 |
Gilead Calistoga Llc |
Novel quinoxaline inhibitors of pi3k
|
|
AR090548A1
(es)
|
2012-04-02 |
2014-11-19 |
Incyte Corp |
Azaheterociclobencilaminas biciclicas como inhibidores de pi3k
|
|
AR091079A1
(es)
|
2012-05-18 |
2014-12-30 |
Incyte Corp |
Derivados de pirrolopirimidina y pirrolopiridina sustituida con piperidinilciclobutilo como inhibidores de jak
|
|
CN104918945B
(zh)
|
2012-11-01 |
2018-01-05 |
因赛特公司 |
作为jak抑制剂的三环稠合噻吩衍生物
|
|
TWI841376B
(zh)
*
|
2013-03-01 |
2024-05-01 |
美商英塞特控股公司 |
吡唑并嘧啶衍生物治療PI3Kδ相關病症之用途
|
|
SI2970291T1
(sl)
|
2013-03-15 |
2022-07-29 |
Janssen Pharmaceutica, N.V. |
Postopki in vmesne spojine za pripravo zdravila
|
|
PL3527263T3
(pl)
|
2013-05-17 |
2021-05-17 |
Incyte Corporation |
Pochodne bipirazolu jako inhibitory jak
|
|
DK3129021T3
(da)
|
2014-04-08 |
2020-11-09 |
Incyte Corp |
Behandling af b-celle-maligniteter ved en kombination af jak- og pi3k-inhibitorer
|
|
SG11201606762PA
(en)
|
2014-05-27 |
2016-09-29 |
Almirall Sa |
Combination
|
|
US10077277B2
(en)
|
2014-06-11 |
2018-09-18 |
Incyte Corporation |
Bicyclic heteroarylaminoalkyl phenyl derivatives as PI3K inhibitors
|
|
AR103297A1
(es)
|
2014-12-30 |
2017-05-03 |
Forma Therapeutics Inc |
Pirrolo y pirazolopirimidinas como inhibidores de la proteasa 7 específica de ubiquitina
|
|
LT3831833T
(lt)
|
2015-02-27 |
2023-02-27 |
Incyte Holdings Corporation |
Pi3k inhibitoriaus gamybos būdai
|
|
US9732097B2
(en)
|
2015-05-11 |
2017-08-15 |
Incyte Corporation |
Process for the synthesis of a phosphoinositide 3-kinase inhibitor
|
|
US20160362424A1
(en)
|
2015-05-11 |
2016-12-15 |
Incyte Corporation |
Salts of (s)-7-(1-(9h-purin-6-ylamino)ethyl)-6-(3-fluorophenyl)-3-methyl-5h-thiazolo[3,2-a]pyrimidin-5-one
|
|
US9988401B2
(en)
|
2015-05-11 |
2018-06-05 |
Incyte Corporation |
Crystalline forms of a PI3K inhibitor
|
|
WO2019232188A1
(en)
|
2018-06-01 |
2019-12-05 |
Incyte Corporation |
Dosing regimen for the treatment of pi3k related disorders
|